Company Name InfraReDx
Mailing Address 34 Third Avenue Burlington, MA 01803
Company Description The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical study.
Proceeds Purposes Funds from the financing are being used to support the full commercial launch of the LipiScan IVUS Coronary Imaging System, the world’s first and only intravascular imaging system that combines and co-registers grayscale intravascular ultrasound (IVUS) with InfraReDx’s proprietary near infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology.